Accelerate Diagnostics Inc. Stock
Accelerate Diagnostics Inc. dominated the market today, gaining €0.090 (8.110%).
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | 8.110% | 50.000% | 36.364% | -82.090% | -66.667% | -97.857% | -99.284% |
MicroVision Inc | -0.440% | -0.659% | -25.466% | -72.009% | -58.210% | -91.270% | 46.583% |
Fonar Corp. New | -1.410% | -2.098% | -12.500% | -12.500% | -20.904% | -3.448% | -22.950% |
Allscripts Healthcare | - | 0.000% | 4.348% | -33.945% | -22.162% | -48.571% | -17.846% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat